Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | FABP7 | O15540 | 1/20 | 0.43 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.42 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.42 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28976958 | 0.86 | HPGD (0.49) | HPGDGLATSHRL3MBTL1TDP1 | |
| SCHEMBL606466 | 0.81 | TSHR (0.55) | HPGDTSHRL3MBTL1TDP1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL3494457 | 0.80 | TSHR (0.57) | HPGDTSHRSMN1; SMN2NPC1RAB9A | |
| SCHEMBL10917021 | 0.78 | FABP7 (0.58) | HPGDTSHRL3MBTL1TDP1SMN1; SMN2 | |
| SCHEMBL280126 | 0.78 | FABP7 (0.58) | HPGDTSHRL3MBTL1TDP1SMN1; SMN2 | |
| SCHEMBL6666657 | 0.78 | FABP7 (0.58) | HPGDTSHRL3MBTL1TDP1SMN1; SMN2 | |
| SCHEMBL5222777 | 0.78 | TSHR (0.52) | GLATSHRSMN1; SMN2NPC1RAB9A | |
| SCHEMBL1001991 | 0.78 | TSHR (0.52) | GLATSHRSMN1; SMN2NPC1RAB9A | |
| SCHEMBL15626865 | 0.78 | TSHR (0.52) | GLATSHRSMN1; SMN2NPC1RAB9A | |
| SCHEMBL13452120 | 0.78 | CYP2C19 (0.56) | HPGDTSHRL3MBTL1TDP1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115916771-B | Multi-target antitumor compound and preparation method and application thereof | 浙江华海药业股份有限公司 | 2025-04-01 | — | — | CN | disclosed |
| CN-115916771-A | Multi-target antitumor compound and preparation method and application thereof | 浙江华海药业股份有限公司 | 2023-04-04 | — | — | CN | disclosed |
| EP-0923553-B1 | STABLE NON-HYGROSCOPIC CRYSTALLINE FORM OF N- N-N-(4-(PIPERIDIN-4-YL)BUTANOYL)-N-ETHYLGLYCYL COMPOUNDS | AVENTIS PHARMA INC (US) | 2008-03-26 | — | — | EP | disclosed |
| US-6753409-B1 | FOR TREATMENT OF MYOCARDIAL INFARCTION, STROKE, PERIPHERAL ARTERIAL DISEASE AND DISSEMINATED INTRAVASCULAR COAGULATION | AVENTIS PHARMACEUTICALS INC. | 2004-06-22 | — | — | US | disclosed |
| CN-1491942-A | Non humidity suction stable crystalline form of N-[N-N-(4-piperidine-4-yl)-N-ethyl glycyl) compound | ���µ�˹ҩ����Ʒ��˾ | 2004-04-28 | — | — | CN | disclosed |
| EP-1142587-A1 | REMEDIES FOR PAIN | MEIJI SEIKA KAISHA LTD. (JP) | 2001-10-10 | — | — | EP | disclosed |
| EP-0929572-A4 | ANTITHROMBOTIC AZACYCLOALKYLALKANOYL PEPTIDES AND PSEUDOPEPTIDES | AVENTIS PHARM PROD INC (US) | 2001-09-12 | — | — | EP | disclosed |
| US-6153588-A | USEFUL IN PROPHYLAXIS AND THREAPY OF THROMBOSIS ASSOCIATED WITH DISEASE STATES SUCH AS MYOCARDIAL INFARCTION, STROKE, PERIPHERAL ARTERIAL DISEASE AND DISSEMINATED INTRAVASCULAR COAGULATION | AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) | 2000-11-28 | — | — | US | disclosed |
| EP-0923553-A4 | STABLE NON-HYGROSCOPIC CRYSTALLINE FORM OF N- N-N-(4-(PIPERIDIN-4-YL)BUTANOYL)-N-ETHYLGLYCYL] COMPOUNDS | RHONE POULENC RORER PHARMA (US) | 1999-12-08 | — | — | EP | disclosed |
| CN-1231659-A | Stable, non-hygroscopic crystalline forms of N [ N-N- (4-piperidin-4-yl) butyryl) -N-ethylglycyl ] compounds | PHONE POULENC RORER PHARMACEUT (US) | 1999-10-13 | — | — | CN | disclosed |
| CN-1231671-A | Antithrombotic azacycloalkylakanoyl peptides and pseudopeptides | PHONE POULENC RORER PHARMACEUT (US) | 1999-10-13 | — | — | CN | disclosed |
| EP-0929572-A1 | ANTITHROMBOTIC AZACYCLOALKYLALKANOYL PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 1999-07-21 | — | — | EP | disclosed |
| EP-0923553-A1 | STABLE NON-HYGROSCOPIC CRYSTALLINE FORM OF N- N-N-(4-(PIPERIDIN-4-YL)BUTANOYL)-N-ETHYLGLYCYL] COMPOUNDS | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 1999-06-23 | — | — | EP | disclosed |
| US-5780590-A | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1998-07-14 | — | — | US | disclosed |
| WO-1998017678-A1 | ANTITHROMBOTIC AZACYCLOALKYLALKANOYL PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1998-04-30 | — | — | WO | disclosed |
| WO-1998007696-A1 | STABLE NON-HYGROSCOPIC CRYSTALLINE FORM OF N-[N-N-(4-(PIPERIDIN-4-YL)BUTANOYL)-N-ETHYLGLYCYL] COMPOUNDS | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1998-02-26 | — | — | WO | disclosed |